論文

査読有り
2012年5月15日

FGF2 mediates mouse spermatogonial stem cell self-renewal via upregulation of Etv5 and Bcl6b through MAP2K1 activation

Development
  • Kei Ishii
  • ,
  • Mito Kanatsu-Shinohara
  • ,
  • Shinya Toyokuni
  • ,
  • Takashi Shinohara

139
10
開始ページ
1734
終了ページ
1743
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1242/dev.076539

Fibroblast growth factor 2 (FGF2) and glial cell line-derived neurotrophic factor (GDNF) are required to recapitulate spermatogonial stem cell (SSC) self-renewal in vitro. Although studies have revealed the role of the GDNF signaling pathway in SSCs, little is known about how FGF2 is involved. In the present study, we assessed the role of the FGF2 signaling pathway using a mouse germline stem (GS) cell culture system that allows in vitro expansion of SSCs. Adding GDNF or FGF2 induced phosphorylation of MAPK1/3, and adding the MAP2K1 inhibitor PD0325091 reduced GS cell proliferation and MAPK1/3 phosphorylation. Moreover, GS cells transfected with an activated form of Map2k1 not only upregulated Etv5 and Bcl6b gene expression, but also proliferated in an FGF2-independent manner, suggesting that they act downstream of MAP2K1 signaling to drive SSC self-renewal. Although GS cells transfected with Map2k1, Etv5 or Bcl6b showed normal spermatogonial markers, transplanting GS cells expressing Bcl6b into infertile mouse testes resulted in the formation of a germ cell tumor, suggesting that excessive self-renewal signals causes tumorigenic conversion. These results show that FGF2 depends on MAP2K1 signaling to drive SSC self-renewal via upregulation of the Etv5 and Bcl6b genes. © 2012. Published by The Company of Biologists Ltd.

リンク情報
DOI
https://doi.org/10.1242/dev.076539
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/22491947
ID情報
  • DOI : 10.1242/dev.076539
  • ISSN : 0950-1991
  • ISSN : 1477-9129
  • PubMed ID : 22491947
  • SCOPUS ID : 84859843774

エクスポート
BibTeX RIS